“…AF prevalence is low in the general population of SSA at <1% and increases with age [3,15,16], 3-7% in hospital cardiology admissions or newly diagnosed cardiovascular diseases [17][18][19][20][21], 16-22% in heart failure patients [22,23], 10-14% in newly diagnosed and 18-28% in established rheumatic heart disease (RHD) patients [24][25][26], 25% in patients with tuberculous pericarditis [27], 6% de novo cases post-cardiac surgery [28], 9.5% in pregnant women with structural heart disease [29], 2-10% of de novo stroke patients [30][31][32][33], and varies between 25-65% in patients attending oral anti-coagulation clinics in SSA [34][35][36]. In SSA there is a high proportion of permanent AF (12-81.4% across studies) and persistent AF (9.6-70.6%), compared to prevalence of paroxysmal AF (8.9-50%) [20,[37][38][39][40][41] as shown in Table 1. Prominent risk factors or comorbidities associated with AF/AFL in SSA are hypertension, which is observed in 50-87% of cases, heart failure 32-64%, diabetes 4-63%, RHD 15-38%, dilated cardiomyopathy 16-38%, stroke 3-40%, and CAD 1.2-26% of AF/AFL patients ( Table 1).…”